Loop Capital starts Walgreens Boots at Buy, sees higher growth from healthcare

As previously reported, Loop Capital analyst Joseph France initiated coverage of Walgreens Boots Alliance with a Buy rating and $45 price target. The company’s new healthcare platform will "significantly enhance" the value of its stores to consumers by affording them more convenient access to healthcare services, the analyst tells investors in a research note. The firm adds that Walgreens’ assembled portfolio of health care providers should strengthen its core retail business and accelerate its growth and profitability by increasing its engagement with consumers.